Cameron
reelected to Lyme Disease Society Board.
Date: 10/29/2005 Philadelphia– Daniel J. Cameron, M.D., M.P.H. private practice and president of First Medical Assocates has been reelected to the board of the International Lyme and Associated Diseases Society (ILADS). ILADS is a nonprofit, international, multidisciplinary medical society, dedicated to the diagnosis and appropriate treatment of Lyme and its associated diseases. ILADS promotes understanding of Lyme and its associated diseases through research and education and strongly supports physicians and other health care professionals dedicated to advancing the standard of care for Lyme and its associated diseases. “The board is composed of those individuals who have made major contributions to the advancement of the Lyme disease," said past board president Andrea Gaito. Cameron joined ILADS in 2002 and spearheaded the development of evidence -based treatment guidelines for Lyme disease. The guidelines were published following peer-review and availabe on medline. The guidelines were further recognized and listed on the National Guideline Clearinghouse. Cameron recieved both M.D. and M.P.H. degrees from the University of Minnesota. His M.P.H. degree was in Epidemiology from the School of Public Health. After completing a residency in Internal Medicine at Beth Israel Medical Center in Manhatten and an Community and Preventive Medicine Residency at Mt. Sinai in Manhatte, Cameron began his career as assistant professor of medicine in geriatrics at New York Medical College, Vahalla, New York. His active clinical practice in Internal Medicine and Lyme Disease becan in 1997. One of the country’s leading Lyme disease investigators, Cameron’s research has had a major impact on understanding the diagnosis and treatment of chronci Lyme disease. Cameron has presented over 50 scientific papers including the results of his recently completed double-blind randomized placebo-controlled clincial trial of Lyme disease. Cameron quality of life paper concluded that the quality of life of chronic Lyme disease patients is as severe as patients with heart disease. His second paper validated the ILADS treatment guidelines.
|